LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
11.54
-0.03 (-0.26%)
At close: Jan 12, 2026, 4:00 PM EST
11.54
0.00 (0.00%)
After-hours: Jan 12, 2026, 4:10 PM EST
LENSAR Employees
LENSAR had 140 employees as of December 31, 2024. The number of employees increased by 10 or 7.69% compared to the previous year.
Employees
140
Change (1Y)
10
Growth (1Y)
7.69%
Revenue / Employee
$422,436
Profits / Employee
-$368,029
Market Cap
137.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 140 | 10 | 7.69% |
| Dec 31, 2023 | 130 | 20 | 18.18% |
| Dec 31, 2022 | 110 | 0 | - |
| Dec 31, 2021 | 110 | 10 | 10.00% |
| Dec 31, 2020 | 100 | 25 | 33.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LNSR News
- 2 months ago - LENSAR® Reports Third Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 4 months ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - LENSAR Reports Second Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 7 months ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire
- 8 months ago - LENSAR Reports First Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 11 months ago - LENSAR, Inc. (LNSR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - GlobeNewsWire
- 11 months ago - LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 - GlobeNewsWire